Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duesbery

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Nature|April 27, 2002
Developmental biology: an arresting activityNicholas S Duesbery, George F Vande Woude
Journal of Applied Microbiology|September 4, 1999
Anthrax lethal factor causes proteolytic inactivation of mitogen-activated protein kinase kinaseN S Duesbery, G F Vande Woude
Methods in Enzymology|April 17, 2008
Biological and biochemical characterization of anthrax lethal factor, a proteolytic inhibitor of MEK signaling pathwaysJennifer L Bromberg-White, Nicholas S Duesbery
Cellular and Molecular Life Sciences : CMLS|October 20, 1999
Anthrax toxinsN S Duesbery, G F Vande Woude
Toxins|November 10, 2011
Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxinJennifer Bromberg-White, Chih-Shia Lee, Nicholas Duesbery
Cell Cycle (Georgetown, Tex.)|November 14, 2002
Anthrax, MEK and cancerJ F Bodart, A Chopra, X Liang, et al.
Plos One|September 15, 2009
Perturbation of mouse retinal vascular morphogenesis by anthrax lethal toxinJennifer L Bromberg-White, Elissa Boguslawski, Nicholas S Duesbery
Nature Medicine|July 8, 1999
MEK wars, a new front in the battle against cancerN S Duesbery, C P Webb, G F Vande Woude
Briefings in Functional Genomics|July 4, 2012
MEK genomics in development and diseaseJennifer L Bromberg-White, Nicholas J Andersen, Nicholas S Duesbery
The Journal of Biological Chemistry|January 11, 2003
Anthrax lethal factor proteolysis and inactivation of MAPK kinaseArun P Chopra, Sherrie A Boone, Xudong Liang, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Nature|April 27, 2002
Developmental biology: an arresting activityNicholas S Duesbery, George F Vande Woude
Journal of Applied Microbiology|September 4, 1999
Anthrax lethal factor causes proteolytic inactivation of mitogen-activated protein kinase kinaseN S Duesbery, G F Vande Woude
Methods in Enzymology|April 17, 2008
Biological and biochemical characterization of anthrax lethal factor, a proteolytic inhibitor of MEK signaling pathwaysJennifer L Bromberg-White, Nicholas S Duesbery
Cellular and Molecular Life Sciences : CMLS|October 20, 1999
Anthrax toxinsN S Duesbery, G F Vande Woude
Toxins|November 10, 2011
Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxinJennifer Bromberg-White, Chih-Shia Lee, Nicholas Duesbery
Cell Cycle (Georgetown, Tex.)|November 14, 2002
Anthrax, MEK and cancerJ F Bodart, A Chopra, X Liang, et al.
Plos One|September 15, 2009
Perturbation of mouse retinal vascular morphogenesis by anthrax lethal toxinJennifer L Bromberg-White, Elissa Boguslawski, Nicholas S Duesbery
Nature Medicine|July 8, 1999
MEK wars, a new front in the battle against cancerN S Duesbery, C P Webb, G F Vande Woude
Briefings in Functional Genomics|July 4, 2012
MEK genomics in development and diseaseJennifer L Bromberg-White, Nicholas J Andersen, Nicholas S Duesbery
The Journal of Biological Chemistry|January 11, 2003
Anthrax lethal factor proteolysis and inactivation of MAPK kinaseArun P Chopra, Sherrie A Boone, Xudong Liang, et al.
Pageof 7